{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:07:40Z","timestamp":1771034860093,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075905","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T17:17:36Z","timestamp":1380907056000},"page":"e75905","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia\/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents"],"prefix":"10.1371","volume":"8","author":[{"given":"Dong","family":"Wha Jun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihwa","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Kyung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"T Helleday","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1158\/1078-0432.CCR-06-1269","article-title":"Targeting the double-strand DNA break repair pathway as a therapeutic strategy","volume":"12","author":"CJ Lord","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2005.09.004","article-title":"DNA repair inhibition: a selective tumour targeting strategy","volume":"11","author":"S Madhusudan","year":"2005","journal-title":"Trends Mol Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pharmthera.2012.10.009","article-title":"Targeting DNA repair mechanisms in cancer","volume":"137","author":"JM Furgason","year":"2013","journal-title":"Pharmacol Therapeutics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1517\/13543784.16.9.1467","article-title":"Melphalan: old and new uses of a still master drug for multiple myeloma","volume":"16","author":"P Musto","year":"2007","journal-title":"Expert Opin Invest Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2174\/092986706776872970","article-title":"Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin","volume":"13","author":"AS Abu-Surrah","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjc.1992.169","article-title":"Cisplatin and its analogues in the treatment of advanced breast cancer: a review","volume":"65","author":"IE Smith","year":"1992","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia\u2013BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"T Taniguchi","year":"2003","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00109-006-0153-2","article-title":"The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents","volume":"85","author":"CC Chen","year":"2007","journal-title":"J Mol Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood-2004-11-4286","article-title":"The FA\/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells","volume":"106","author":"Q Chen","year":"2005","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway","volume":"5","author":"D Chirnomas","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.24039","article-title":"A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway","volume":"124","author":"I Landais","year":"2009","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood-2002-01-0278","article-title":"S-phase\u2013specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51","volume":"100","author":"T Taniguchi","year":"2002","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1097-2765(01)00173-3","article-title":"Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway","volume":"7","author":"I Garcia-Higuera","year":"2001","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1101\/gad.1370505","article-title":"The Fanconi Anemia\/BRCA pathway: new faces in the crowd","volume":"19","author":"RD Kennedy","year":"2005","journal-title":"Genes Dev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1087057110392993","article-title":"Development of a high-content screening method for chemicals modulating DNA damage response","volume":"16","author":"S Kim","year":"2011","journal-title":"J Biomol Screen"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2012.01977.x","article-title":"Characterization of DDRI-18 (3, 3'-(1H, 3'H-5, 5'-bibenzo [d] imidazole-2, 2'-diyl) dianiline), a novel small molecule inhibitor modulating the DNA damage response","volume":"167","author":"DW Jun","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"I Prassas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2006.01745.x","article-title":"New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target","volume":"261","author":"A Aperia","year":"2007","journal-title":"J Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2007.03.009","article-title":"Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair","volume":"129","author":"A Smogorzewska","year":"2007","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","article-title":"DNA interstrand crosslink repair and cancer","volume":"11","author":"AJ Deans","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.1210\/jc.2011-2671","article-title":"Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing","volume":"97","author":"L Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/bjc.2012.159","article-title":"Quiescence and \u03b3H2AX in neuroblastoma are regulated by ouabain\/Na, K-ATPase","volume":"106","author":"H Hiyoshi","year":"2012","journal-title":"Br J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.221315298","article-title":"Ouabain, a steroid hormone that signals with slow calcium oscillations","volume":"98","author":"O Aizman","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref26","first-page":"1693","article-title":"Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells","volume":"61","author":"F Brouillard","year":"2001","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mi.3.3.157","article-title":"Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function","volume":"3","author":"Z Xie","year":"2003","journal-title":"Mol Interventions"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"T-C Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI31245","article-title":"Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated","volume":"117","author":"RD Kennedy","year":"2007","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0360-3016(88)90132-0","article-title":"Ouabain sensitizes tumor cells but not normal cells to radiation","volume":"15","author":"TS Lawrence","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/np900210m","article-title":"Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs","volume":"72","author":"J Felth","year":"2009","journal-title":"J Nat Prod"},{"key":"ref32","first-page":"68","article-title":"A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment","volume":"1","author":"EA Platz","year":"2011"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1593\/neo.05850","article-title":"Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers","volume":"8","author":"T Mijatovic","year":"2006","journal-title":"Neoplasia (New York, NY)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"50355","DOI":"10.1074\/jbc.M305378200","article-title":"Cell Signaling Microdomain with Na, K-ATPase and Inositol 1,4,5-Trisphosphate Receptor Generates Calcium Oscillations","volume":"278","author":"A Miyakawa-Naito","year":"2003","journal-title":"J Biol Chem"},{"key":"ref35","first-page":"3807","article-title":"Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells","volume":"60","author":"DJ McConkey","year":"2000","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.freeradbiomed.2011.06.016","article-title":"Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation","volume":"51","author":"C-M Xie","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e44254","DOI":"10.1371\/journal.pone.0044254","article-title":"Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells","volume":"7","author":"Y Li","year":"2012","journal-title":"PLOS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2008-09-181420","article-title":"Distinct roles of stress-activated protein kinases in Fanconi anemia type C\u2013deficient hematopoiesis","volume":"113","author":"MR Saadatzadeh","year":"2009","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:51:18Z","timestamp":1540515078000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075905"}},"subtitle":[],"editor":[{"given":"Peiwen","family":"Fei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075905","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}